{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:19:07Z","timestamp":1790309947465,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Linezolid has been increasingly used in tertiary NICUs. The objectives of this study were to explore the indications of these linezolid prescriptions, to analyze a possible misuse and to provide solutions to avoid such misuse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A monocentric retrospective cohort study included all neonates hospitalized in one tertiary NICU between January 1st, 2010 and December 31st, 2019 and who received at least one administration of linezolid. These data were confronted to epidemiological and antibiotic use data from the same NICU. Two independent pediatricians secondarily classified linezolid uses as adequate or not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 66 infections in 57 patients led to linezolid use. Most patients were pre-term and 21 patients (37%) died. Infections were mainly related to methicillin-resistant coagulase negative staphylococci and were frequently either pneumoniae (35%) or isolated bacteremia (48%), including 25 persistent bacteremia (64% of the 39 bacteremia). Need for a better tissue distribution or first-line treatment failure were the main reasons to initiate linezolid. Linezolid was administered for a median duration of 7 [3;10] days. No side effects were reported. Twenty-two (33%) of the 66 linezolid prescriptions were retrospectively classified as inadequate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A rapid increase in linezolid prescriptions has been observed in our tertiary NICU, from 2014 to 2019, with 33% inadequate uses. This worrisome trend should lead to search for therapeutic alternatives and to work on antibiotic stewardship to prevent the emergence of new antimicrobial bacterial resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-020-00818-2","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T08:03:02Z","timestamp":1600848182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increasing use of linezolid in a tertiary NICU during a 10-year period: reasons and concerns for the future"],"prefix":"10.1186","volume":"9","author":[{"given":"Lucie","family":"Matrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Plaisant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Claris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-4641","authenticated-orcid":false,"given":"Marine","family":"Butin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","volume":"379","author":"L Liu","year":"2012","unstructured":"Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151\u201361.","journal-title":"Lancet."},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1542\/peds.2012-0147","volume":"129","author":"RA Polin","year":"2012","unstructured":"Polin RA, Denson S, Brady MT, Newborn the COFA, Diseases the COI. Epidemiology and diagnosis of health care\u2013associated infections in the NICU. Pediatrics. 2012;129:e1104\u20139.","journal-title":"Pediatrics"},{"key":"818_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jpeds.2012.11.089","volume":"162","author":"NS Boghossian","year":"2013","unstructured":"Boghossian NS, Page GP, Bell EF, Stoll BJ, Murray JC, Cotten CM, et al. Late-onset sepsis in very low birth weight infants from singleton and multiple gestation births. J Pediatr. 2013;162:1120\u20134.e1.","journal-title":"J Pediatr"},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"F547","DOI":"10.1136\/archdischild-2017-313203","volume":"103","author":"B Cailes","year":"2018","unstructured":"Cailes B, Kortsalioudaki C, Buttery J, Pattnayak S, Greenough A, Matthes J, et al. Epidemiology of UK neonatal infections: the neonIN infection surveillance network. Arch Dis Child Fetal Neonatal Ed. 2018;103:F547\u201353.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","volume":"138","author":"RC Moellering","year":"2003","unstructured":"Moellering RC. Linezolid: the first Oxazolidinone antimicrobial. Ann Intern Med. 2003;138:135.","journal-title":"Ann Intern Med"},{"key":"818_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00228-015-1813-3","volume":"71","author":"M Sicard","year":"2015","unstructured":"Sicard M, Launay E, Caillon J, Jacqueline C, Legrand A, Deslandes G, et al. Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants. Eur J Clin Pharmacol. 2015;71:611\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"818_CR7","first-page":"iv7","volume":"66","author":"MS Dryden","year":"2011","unstructured":"Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother. 2011;66:iv7\u201315.","journal-title":"J Antimicrob Chemother"},{"key":"818_CR8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/INF.0000000000002619","volume":"39","author":"M Sicard","year":"2020","unstructured":"Sicard M, Moussa A, Barrington K, Martin B, Luu TM, Ting JY, et al. Neonatal and neurodevelopmental outcomes following linezolid for coagulase-negative staphylococcal infection: real world evidence. Pediatr Infect Dis J. 2020;39:598\u2013603.","journal-title":"Pediatr Infect Dis J"},{"key":"818_CR9","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/jac\/dkx059","volume":"72","author":"AC Blanchard","year":"2017","unstructured":"Blanchard AC, Fortin E, Laferri\u00e8re C, Goyer I, Moussa A, Autmizguine J, et al. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit. J Antimicrob Chemother. 2017;72:1812\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"e0139097","DOI":"10.1371\/journal.pone.0139097","volume":"10","author":"E Buccellato","year":"2015","unstructured":"Buccellato E, Melis M, Biagi C, Donati M, Motola D, Vaccheri A. Use of antibiotics in pediatrics: 8-years survey in Italian hospitals. PLoS One. 2015;10:e0139097.","journal-title":"PLoS One"},{"key":"818_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/INF.0000000000001769","volume":"37","author":"B Bagga","year":"2018","unstructured":"Bagga B, Buckingham S, Arnold S, Nesbitt A, Guimera D, Lee K. Increasing linezolid-resistant enterococcus in a Children\u2019s hospital. Pediatr Infect Dis J. 2018;37:242\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"818_CR12","doi-asserted-by":"publisher","first-page":"e000643","DOI":"10.1136\/bmjpo-2020-000643","volume":"4","author":"B McMullan","year":"2020","unstructured":"McMullan B, Cooper C, Spotswood N, James R, Jones C, Konecny P, et al. Antibiotic prescribing in neonatal sepsis: an Australian nationwide survey. BMJ Paediatr Open. 2020;4:e000643.","journal-title":"BMJ Paediatr Open"},{"key":"818_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clinthera.2010.01.019","volume":"32","author":"E Chiappini","year":"2010","unstructured":"Chiappini E, Conti C, Galli L, de Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther. 2010;32:66\u201388.","journal-title":"Clin Ther"},{"key":"818_CR14","doi-asserted-by":"publisher","first-page":"e0164136","DOI":"10.1371\/journal.pone.0164136","volume":"11","author":"J Chong","year":"2016","unstructured":"Chong J, Caya C, L\u00e9vesque S, Quach C. Heteroresistant Vancomycin intermediate coagulase negative staphylococcus in the NICU: a systematic review. PLoS One. 2016;11:e0164136.","journal-title":"PLoS One"},{"key":"818_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.arcped.2013.06.024","volume":"20","author":"J-P Rasigade","year":"2013","unstructured":"Rasigade J-P, Bensaid M, Butin M, Picaud J-C, Laurent F. Actualit\u00e9s Sur la prise en charge des infections n\u00e9onatales nosocomiales tardives \u00e0 staphylocoque \u00e0 coagulase n\u00e9gative. Arch P\u00e9diatrie. 2013;20:1028\u201333.","journal-title":"Arch P\u00e9diatrie"},{"key":"818_CR16","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"818_CR17","doi-asserted-by":"publisher","first-page":"iv23","DOI":"10.1093\/jac\/dkr133","volume":"66","author":"S Garazzino","year":"2011","unstructured":"Garazzino S, Tovo P-A. Clinical experience with linezolid in infants and children. J Antimicrob Chemother. 2011;66:iv23\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"818_CR18","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1093\/jac\/dkz367","volume":"74","author":"KE Wardenburg","year":"2019","unstructured":"Wardenburg KE, Potter RF, D\u2019Souza AW, Hussain T, Wallace MA, Andleeb S, et al. Phenotypic and genotypic characterization of linezolid-resistant enterococcus faecium from the USA and Pakistan. J Antimicrob Chemother. 2019;74:3445\u201352.","journal-title":"J Antimicrob Chemother"},{"key":"818_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jac\/dks354","volume":"68","author":"B Gu","year":"2013","unstructured":"Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant staphylococcus. J Antimicrob Chemother. 2013;68:4\u201311.","journal-title":"J Antimicrob Chemother"},{"key":"818_CR20","first-page":"470","volume":"115","author":"N Bayram","year":"2017","unstructured":"Bayram N, D\u00fczg\u00f6l M, Kara A, \u00d6zdemir FM, Devrim I. Linezolid-related adverse effects in clinical practice in children. Arch Argent Pediatr. 2017;115:470\u20135.","journal-title":"Arch Argent Pediatr"},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2014.06.017","volume":"44","author":"A Ozkaya-Parlakay","year":"2014","unstructured":"Ozkaya-Parlakay A, Kara A, Celik M, Ozsurekci Y, Oncel EK, Ceyhan M, et al. Early lactic acidosis associated with linezolid therapy in paediatric patients. Int J Antimicrob Agents. 2014;44:334\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"818_CR22","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1542\/peds.2010-2125","volume":"127","author":"S Nambiar","year":"2011","unstructured":"Nambiar S, Rellosa N, Wassel RT, Borders-Hemphill V, Bradley JS. Linezolid-associated peripheral and optic neuropathy in children. Pediatrics. 2011;127:e1528\u201332.","journal-title":"Pediatrics."},{"key":"818_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s40265-017-0745-x","volume":"77","author":"G Li","year":"2017","unstructured":"Li G, Standing JF, Bielicki J, Hope W, van den Anker J, Heath PT, et al. The potential role of Fosfomycin in neonatal sepsis caused by multidrug-resistant bacteria. Drugs. 2017;77:941\u201350.","journal-title":"Drugs."},{"key":"818_CR24","first-page":"55","volume":"32","author":"F Baquero-Artigao","year":"2019","unstructured":"Baquero-Artigao F. Rabes T del R. Fosfomycin in the pediatric setting: evidence and potential indications. Rev Esp Quimioter. 2019;32:55\u201361.","journal-title":"Rev Esp Quimioter"},{"key":"818_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1573396312666160603164511","volume":"12","author":"D Gkentzi","year":"2016","unstructured":"Gkentzi D, Kolyva S, Spiliopoulou I, Marangos M, Dimitriou G. Treatment options for persistent coagulase negative staphylococcal bacteremia in neonates. Curr Pediatr Rev. 2016;12:199\u2013208.","journal-title":"Curr Pediatr Rev"},{"key":"818_CR26","first-page":"342","volume":"7","author":"SN Salerno","year":"2018","unstructured":"Salerno SN, Bernhardt J, Laughon M, Jhaveri R, Massaro M, Gonzalez D. Pharmacokinetics of Ceftaroline in a preterm infant with methicillin-resistant staphylococcus Aureus pneumonia. J Pediatr Infect Dis Soc. 2018;7:342\u20135.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"818_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fped.2018.00294","volume":"6","author":"KE Steinmann","year":"2018","unstructured":"Steinmann KE, Lehnick D, Buettcher M, Schwendener-Scholl K, Daetwyler K, Fontana M, et al. Impact of empowering leadership on antimicrobial stewardship: a single center study in a neonatal and pediatric intensive care unit and a literature review. Front Pediatr. 2018;6:294.","journal-title":"Front Pediatr"},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/INF.0000000000002039","volume":"38","author":"JY Ting","year":"2019","unstructured":"Ting JY, Paquette V, Ng K, Lisonkova S, Hait V, Shivanada S, et al. Reduction of inappropriate antimicrobial prescriptions in a tertiary neonatal intensive care unit after antimicrobial stewardship care bundle implementation. Pediatr Infect Dis J. 2019;38:54\u20139.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00818-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T19:32:19Z","timestamp":1632339139000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00818-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00818-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-46744\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-46744\/v1","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local institutional ethics committee (Hospices Civils de Lyon, chaired by Pr Jean-Fran\u00e7ois GU\u00c9RIN) under the number 20\u201362 and was registered to the French data protection authority under the number 20\u2013137.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written information was delivered to the families of the included patients to give them opportunity to decline participation to this study; none declined to participate. In accordance with French legislation, a written consent was not required owing to the observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}